Our new study in Blood! We show that tractable peripheral blood monocyte-based gene expression signatures can detect IL-17- and CSF-1-dysregulated cGVHD and are detectable in patients. This could lead to rational therapy selection.
https://ashpublications.org/blood/article-abstract/doi/10.1182/blood.2024025337/535653/Defining-pathogenic-IL-17-and-CSF-1-gene
https://ashpublications.org/blood/article-abstract/doi/10.1182/blood.2024025337/535653/Defining-pathogenic-IL-17-and-CSF-1-gene
Comments